← Back to Search

Behavioral Intervention

Remote Exercise Training for Multiple Sclerosis (FERLAMS Trial)

N/A

Recruiting

Led By Robert Motl, Ph.D

Research Sponsored by University of Illinois at Chicago

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up before and after 16 weeks, baseline and post-intervention

Awards & highlights

FERLAMS Trial Summary

This trial tests a 4-month remotely-delivered exercise program for Hispanics/Latinos with MS to see if it can improve physical function, symptom management, and quality of life. It will also examine how social determinants of health affect the feasibility and effectiveness of the intervention.

Who is the study for?

This trial is for Hispanic/Latino individuals aged 18-65 living in Chicago with MS, who are not currently very active. They must be relapse-free for at least a month, able to walk (with or without help), have internet access, and be safe to exercise.Check my eligibility

What is being tested?

The study tests if a remote 4-month exercise program can improve physical function and quality of life in Hispanics/Latinos with MS. It includes flexibility and aerobic/resistance training guided by coaches compared to a control group.See study design

What are the potential side effects?

Since this is an exercise-based intervention, potential side effects may include muscle soreness, fatigue, or injury related to physical activity. The risk is minimized by ensuring participants are cleared as safe for exercise.

FERLAMS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ before and after 16 weeks, baseline and post-intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~before and after 16 weeks, baseline and post-intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and before and after 16 weeks, baseline and post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Management: Data Management and Safety Reporting During the Study

Process: Participant Recruitment and Retention

Resources: Communication and Monetary Requirements of the Study

+1 more

Secondary outcome measures

Depressive Symptoms

Exercise Behavior

Fatigue Severity

+4 more

Other outcome measures

Social Determinants of Health Factors

FERLAMS Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Exercise Training ProgramExperimental Treatment1 Intervention

Participants will receive a theory-based, remotely-delivered exercise training program that includes aerobic and resistance exercise training.

Group II: Flexibility ProgramActive Control1 Intervention

Participants will receive a remotely-delivered flexibility program, focusing on improving flexibility and range of motion.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Exercise Training Program

2019

N/A

~200

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor

609 Previous Clinical Trials

1,559,259 Total Patients Enrolled

13 Trials studying Multiple Sclerosis

1,656 Patients Enrolled for Multiple Sclerosis

Robert Motl, Ph.DPrincipal InvestigatorUniversity of Illinois Chicago

Media Library

Exercise Training Program (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05998616 — N/A

Multiple Sclerosis Research Study Groups: Exercise Training Program, Flexibility Program

Multiple Sclerosis Clinical Trial 2023: Exercise Training Program Highlights & Side Effects. Trial Name: NCT05998616 — N/A

Exercise Training Program (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05998616 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies available for individuals to participate in this clinical trial?

"The information available on clinicaltrials.gov indicates the this medical trial is no longer welcoming new participants, although it was initially posted in September 1st 2023 and edited up to August 9th 2023. Nevertheless, there are 548 other trials currently open for enrolment."

Answered by AI

What are the prime goals of this exploration?

"The aim of this 16-week study is to evaluate the Communication and Monetary Requirements associated with it. To measure Visual Processing Speed, participants will be tested on their capacity to quickly pair digits with symbols using the Symbol Digit Modalities Test (SDMT). Additionally, Verbal Learning and Memory are assessed by means of California Verbal Learning Test II (CVLT-II) which requires recalling sixteen words for five trials, while Fatigue Severity is determined via scores from the Fatigue Severity Scale (FSS); 1 being minimal fatigue severity up to 7 indicating maximum fatigue level."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Feasibility of Remote Exercise Training for Hispanics/Latinos With MS

Robert W Motl 2024. "Feasibility of Remote Exercise Training for Hispanics/Latinos With MS". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05998616.